In vivo tumor imaging using a near-infrared–labeled endostatin molecule
- 1 February 2004
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 58 (2), 536-541
- https://doi.org/10.1016/j.ijrobp.2003.09.068
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Role of imaging in clinical trials of antiangiogenesis therapy in oncology.Academic Radiology, 2000
- Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelProceedings of the National Academy of Sciences, 2000
- Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a reviewEuropean Journal of Radiology, 1999
- Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinomaCancer, 1999
- Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingNature Medicine, 1998
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Vascular attack as a therapeutic strategy for cancerCancer and Metastasis Reviews, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Endothelial cell proliferation as a novel approach to targeting tumour therapyBritish Journal of Cancer, 1982
- Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesisMicrovascular Research, 1977